Prescribing, Policies and Pathways
or
Clinical area | Documents |
---|---|
Shared Care, Decision Making & Advice and Guidance | 57 |
Medicine / Guideline | Indication | RAG rating | Document type | Place |
---|---|---|---|---|
A frequently asked questions document: Shared care for medicines and NHS shared care and specialist guided prescribing service specification. | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
Amiodarone Shared Care Protcol | Arrythmia | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol | Amber protocol | Shared care protocol | West Essex |
Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol children and young people (methylphenidate, lisdexamfetamine, dexamfetamine, atomoxetine or guanfacine) | Amber protocol | Shared care protocol | West Essex |
Attention deficit hyperactivity disorder (ADHD) | ADHD shared care protocol - children, young people and adults | Amber protocol | Shared care protocol | East and North Hertfordshire, South and West Hertfordshire |
Cannabidiol (Epidiyolex®) | Tertiary care indication (NHSE) Suitable for shared care between tertiary and secondary care providers. Adjunctive treatment with clobazam for treating seizures associated with Dravet syndrome and Lennox-Gastaut syndrome (LGS) | Red | Decision document | Hertfordshire and West Essex ICB |
Shared care | Attention deficit hyperactivity disorder (ADHD) by Private Provider | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Shared Care | Shared Care Principles | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Shared care | Initiation by a Private Provider | Amber protocol | Patient information | Hertfordshire and West Essex ICB |
Acetylcholinesterase (AChE) inhibitor | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
Apomorphine | Parkinson's disease | Red | Decision document | Hertfordshire and West Essex ICB |
Asthma | Inhaled corticosteroids (ICS) choices | Green | Prescribing guideline | Hertfordshire and West Essex ICB |
Bariatric Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Cannabis-based medicinal preparations | Intractable nausea & vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy | Red | Position statement | Hertfordshire and West Essex ICB |
Cenobamate | Focal onset seizures | n/a | NICE technology appraisal | Hertfordshire and West Essex ICB |
Clonidine | Attention deficit hyperactivity disorder (ADHD) | Red | Decision document | Hertfordshire and West Essex ICB |
Delta-9-tetrahydrocannabinol [THC] and cannabidiol [CBD] spray (Sativex®) | Spasticity in multiple sclerosis (MS) | Red | Decision document | Hertfordshire and West Essex ICB |
Donepezil | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
Dual GIP with GLP-1 RA or GLP-1 RA with Insulin guidance document | Type 2 Diabetes | Amber initiation | Prescribing guideline | Hertfordshire and West Essex ICB |
Fludrocortisone | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
Galantamine | Alzheimer's disease dementia | Amber initiation | Decision document | East and North Hertfordshire, South and West Hertfordshire |
Gender Dysphoria | n/a | n/a | Hertfordshire and West Essex ICB | |
How to guide: Searching HWE prescribing guidance website | n/a | n/a | Hertfordshire and West Essex ICB | |
Hysterectomy in Gender Dysphoria | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Inspection - CQC | Managing Medicines in a GP Practice | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
Liothyronine - Position Statement | Hypothyroidism | Amber protocol | Position statement | Hertfordshire and West Essex ICB |
Liothyronine Review Algorithm | Hypothyroidism | Amber protocol | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Lithium Primary Care action plan | Mania, hypomania, bipolar disorder, depression and aggressive or self-harming behaviour | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Low molecular weight heparin (LMWH) | Anticoagulation | Red | Decision document | Hertfordshire and West Essex ICB |
Melatonin | Insomnia - Neurodevelopmental Disorders in patients under the age of 18 years | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
Memantine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
Midodrine | Orthostatic Hypotension | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
Nabilone | Intractable chemotherapy induced nausea and vomiting | Red | Decision document | Hertfordshire and West Essex ICB |
Palliative care formulary | Palliative care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
Penicillamine | Rheumatoid Arthiritis | Amber protocol | n/a | Hertfordshire and West Essex ICB |
Penicillamine | Tertiary care indication (NHSE) | Amber protocol | n/a | Hertfordshire and West Essex ICB |
Prescription | Private consultation | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Prescription - repeat | Prescriber guide with tips | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Rifaximin | Hepatic encephalopathy | Amber initiation | Decision document | Hertfordshire and West Essex ICB |
Rivastigmine | Alzheimer's disease dementia | Amber initiation | Prescribing support document | East and North Hertfordshire, South and West Hertfordshire |
Sacubitril valsartan | Heart failure | Amber initiation | Prescribing support document | Hertfordshire and West Essex ICB |
Sativex® and other licensed cannabis -based medicinal products | Red | Decision document | Hertfordshire and West Essex ICB | |
Sirolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
Tacrolimus oral | Transplant rejection (prescribe by brand) NHSE for existing patients | Amber protocol | n/a | Hertfordshire and West Essex ICB |
User guide for eRD (EMIS and SI) | eRDs | n/a | Prescribing support document | Hertfordshire and West Essex ICB |